Cancer Research UK, Abcodia to develop blood Dx attuned to early-stage cancers

Cancer Research UK, by way of its commercial division known as Cancer Research Technology, will collaborate with Abcodia on new blood tests designed to spot cancers at very early stages. Their work will focus, in part, on identifying biomarkers that will let clinicians detect cancer before patients even have symptoms. And they'll try to fill a diagnostic gap, focusing on cancers for which many screening tests aren't widely in use. Item

Suggested Articles

Coronavirus may not require a front-line battle yet in certain places, but it’s still taxing public health officials preparing for a potential crisis.

Cybernet Manufacturing, maker of medical-grade computer monitors, has unveiled a new, large touchscreen designed to protect against infections.

A startup has raised $12 million to fund its real-time system for monitoring patients undergoing dialysis at home and calling in complications.